TrialClinical and vaccine immunology : CVI2010

Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults.

Pablo Bonvehí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.